Compare DYAI & BIRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DYAI | BIRD |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 26.2M |
| IPO Year | 2003 | 2021 |
| Metric | DYAI | BIRD |
|---|---|---|
| Price | $1.00 | $2.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $8.00 |
| AVG Volume (30 Days) | 220.4K | ★ 315.6K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.22 |
| EPS | ★ N/A | N/A |
| Revenue | $3,090,345.00 | ★ $152,466,000.00 |
| Revenue This Year | $122.79 | N/A |
| Revenue Next Year | $100.00 | $35.12 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.65 | $2.15 |
| 52 Week High | $1.60 | $24.31 |
| Indicator | DYAI | BIRD |
|---|---|---|
| Relative Strength Index (RSI) | 47.49 | 35.05 |
| Support Level | $0.76 | $2.23 |
| Resistance Level | $1.21 | $3.36 |
| Average True Range (ATR) | 0.16 | 0.16 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 10.77 | 30.43 |
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.